Kutatási jelek – Signal Engine

• Current Management of Acute Lymphoblastic Leukemia in Adults | CancerNetwork — Acute lymphoblastic leukemia
• IDEAYA Biosciences Announces Successful FDA Type C Meeting for IDE849, DLL3 TOP1 ADC, on Phase 3 Registrational Trial Design for Potential Accelerated and Full Approval in Extensive Stage Small Cell Lung Cancer — SCLC
• My Stage IV Uterine Leiomyosarcoma Diagnosis: One Step at a Time — Leiomyosarcoma
• Targeted Therapy Drugs for Esophageal Cancer — Esophageal cancer
• Nivolumab Improves Survival in Phase III Head and Neck Cancer Study — Head and neck squamous cell carcinoma
• Trametinib ‘New Standard of Care’ Option for Low-Grade Ovarian Cancer — Ovarian cancer
• Integrating Psilocybin-Assisted Psychotherapy in Comprehensive Cancer Care — Thyroid cancer
• Zanidatamab‑Based Regimens Exhibit Improved PFS in Gastroesophageal Cancers — Thyroid cancer
• A cancer drug gets conditional China approval; its trial showed a 42.5% response rate — Cholangiocarcinoma
• FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer — Pancreatic cancer
• NSCLC: Selecting Therapy Based on PD-L1 Status and Staging — NSCLC
• Neoadjuvant Chemotherapy for Resectable Non‑Small‑Cell Lung Cancer — NSCLC
• FDA Grants Fast Track Designation to VS-7375 for KRAS G12D-Mutated Advanced NSCLC — NSCLC
• Navigating Dramatic Changes and Using Novel Therapies in CLL Management — Chronic lymphocytic leukemia
• Which Treatment Strategies Work Best in CLL Management? — Chronic lymphocytic leukemia
• Chronic Myelogenous Leukemia | CancerNetwork — Acute lymphoblastic leukemia
• Diffuse Large B-Cell Lymphoma: Changing Treatment Paradigms — Diffuse large B-cell lymphoma
• Iza-Bren Yields Statistically Significant Efficacy in Advanced TNBC — Thyroid cancer
• First-in-Human Phase 1a/1b Trial of LY4170156 in Advanced Solid Tumors — Ovarian cancer
• An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment — Glioblastoma